HOME >> BIOLOGY >> NEWS
ASU and Mayo lead 'MAC Attack' to accelerate cancer research

In terms of a medical diagnosis, nothing is more devastating than hearing the "C" word cancer. But now, ASU and Mayo Clinic are hoping that five different C's will become the best arsenal against the big C. The organizations have teamed up to introduce a new research entity called MAC5.

MAC5 is short for the Mayo Clinic ASU Center for Cancer-related Convergence, Cooperation and Collaboration. The new effort will leverage the distinct roles of basic science, technology and clinical medicine to translate discoveries into clinical advances.

"We have been working for the past couple of years with the leaders at Mayo Clinic to build and enhance a relationship between their doctors, who are at the forefront of health care, and ASU's scientists and engineers," said ASU President Michael M. Crow. "We find that the collaborative potential between Mayo and ASU is very high. The openness and intellectual fusion of our educational, scientific, and cultural linkages are at the early stages of what we hope to be a significant and profound relationship to improve health care," Crow said.

"Part of our heritage at Mayo Clinic has been the teamwork demonstrated to bring different disciplines together for the benefit of patients," said Victor Trastek, M.D., CEO of Mayo Clinic in Arizona. "With ASU, we are now just scratching the surface of a great opportunity to work together with scientists, clinicians and patients. This type of collaborative effort is the future in caring for patients and developing the new types of science, devices and therapeutics to advance medicine."

"The alignment in vision and teamwork at the interface between basic science and clinical medicine builds on the complementary strengths of both institutions with a critical goal of bringing value to health care and our patients," said Laurence Miller, M.D., and director for research at Mayo Clinic.

Cancer remains the leading cause of death in the U.S., with over a half
'"/>

Contact: Joe Caspermeyer
joseph.caspermeyer@asu.edu
480-727-0369
Arizona State University
16-Feb-2006


Page: 1 2 3

Related biology news :

1. Defects in critical gene lead to accelerated lung tumor growth
2. Specific type of cell death may accelerate decompensated heart failure
3. Early environmental exposure may accelerate age-related neurodegeneration
4. Scripps research scientists show protein accelerates breast cancer progression in animal models
5. New clues for treatment of disease that causes accelerated aging
6. Penn study finds inhaled anesthetics accelerate the appearance of brain plaque in animals
7. Risk of extinction accelerated due to interacting human threats
8. Boston University, Fraunhofer Gesellschaft form alliance to accelerate biomedical innovation
9. Insect population growth likely accelerated by warmer climate
10. Islands spark accelerated evolution
11. DOE announces $60 million in projects to accelerate scientific discovery through advanced computing

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/6/2020)... , ... February 06, 2020 ... ... research organization (CRO) specializing in complex interventional medical device and pharmaceutical trials, ... Regulatory Strategy. In this newly established role, Dorothy oversees the development and ...
(Date:2/1/2020)... ... , ... Liver cancer, called hepatocellular carcinoma (HCC), occurs each year in more ... is the 5th most common cancer and the 2nd leading cause of cancer deaths. ... of HCC, while China has half of all patients suffering from liver cancer. The ...
(Date:1/29/2020)... Texas (PRWEB) , ... January 29, 2020 , ... ... DNA plasmid, announced it will start production of a DNA vaccine against the ... executed with Inovio Pharmaceuticals. A grant of up to $9 million from the ...
Breaking Biology News(10 mins):
(Date:2/5/2020)... Conn. (PRWEB) , ... February 04, 2020 , ... ... develops tools for characterizing microbiome populations down to the strain level, has announced ... will sell Shoreline Biome’s microbiome kits and other products to companies and research ...
(Date:2/3/2020)... BUDAPEST, Hungary and CAMBRIDGE, Mass. (PRWEB) , ... ... ... headquartered in Budapest with US offices in Cambridge, MA, announce that OmniType, the ... Access Program (EAP) from today. OmniType is a best-in-class product featuring locus-multiplexing and ...
(Date:1/28/2020)... ... January 28, 2020 , ... Today, Salimetrics announced an addition ... Salivary Total Human IgG Assay Kit exemplifies Salimetrics’ 20+ year commitment ... can extend the accuracy and ease of use of salivary bioscience into infectious ...
(Date:1/24/2020)... ... January 24, 2020 , ... The plastic and reconstructive ... Center in New Jersey epitomize the notion that plastic surgery is much more than ... in popular media. , Over the last 20 years NJ Top Docs, Dr. Andrew ...
Breaking Biology Technology:
Cached News: